Stay up to date with the most recent announcements from the media

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Deep Tech

Ophthamology Times

Apr 14, 2025

Eyestem releases positive results from phase 1 trial in patients with geographic atrophy

Eyecyte-RPE trial involved 9 patients with geographic atrophy, using three ascending dose levels of hiPSC-derived RPE cells. No serious adverse events were reported, and patients showed an average vision improvement of 14.9 letters on ETDRS tests.

Deep Tech

New Indian Express

Apr 10, 2025

Robots reimagined: Perceptyne making steely strides

Will robots take over the world? Well, while that is an age-old sci-fi cliffhanger, Perceptyne’s robots aren’t plotting domination — they’re rolling up their sleeves and getting to work.

Enterprise

Entrepreneur

Mar 29, 2025

Expertia AI Secures INR 20 Crore in Pre-Series A, Eyes 3x Revenue Growth in FY25

The newly raised funds will be directed toward product development and the expansion of Expertia's technology team.

Fortune India

Mar 20, 2025

How Endiya Partners 4x return signals strength in early stage strategy amid shifting market dynamics

Endiya has raised corpus for three funds to date, with the first and second being Rs 175 crore and Rs 500 crore, while the corpus for the third fund, which closed recently, is Rs 800 crore.

No items found.

News

Eyestem releases positive results from phase 1 trial in patients with geographic atrophy

Robots reimagined: Perceptyne making steely strides

Expertia AI Secures INR 20 Crore in Pre-Series A, Eyes 3x Revenue Growth in FY25

How Endiya Partners 4x return signals strength in early stage strategy amid shifting market dynamics